Sio Capital Management’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-40
Closed -$196K 77
2021
Q1
$196K Buy
+40
New +$226K 0.04% 88
2020
Q4
Sell
-447
Closed -$174K 92
2020
Q3
$174K Sell
447
-2,130
-83% -$826K 0.03% 85
2020
Q2
$789K Buy
+2,577
New +$647K 0.23% 66
2020
Q1
Sell
-2,018
Closed -$1.5M 73
2019
Q4
$1.5M Sell
2,018
-381
-16% -$223K 0.36% 46
2019
Q3
$1M Sell
2,399
-134
-5% -$146K 0.32% 54
2019
Q2
$2.69M Sell
2,533
-31
-1% -$63.3K 0.65% 46
2019
Q1
$4.63M Buy
2,564
+170
+7% +$445K 1.25% 29
2018
Q4
$4.85M Sell
2,394
-7
-0.3% -$27.9K 1.77% 23
2018
Q3
$7.35M Buy
+2,401
New +$10.2M 2.52% 11

Other funds holding BNGO

Sio Capital Management's BNGO Position: Q2 2021 in Review

Sio Capital Management sold out of Bionano Genomics (BNGO) in Q2 2021, closing a stake of 40 shares — an estimated $196K sold.

Sio Capital Management first reported a position in BNGO in Q3 2018 and held it in 9 quarters. The position peaked at $7.35M in Q3 2018. 152 funds tracked by Wall St. Rank hold BNGO as of Q2 2021.

  • Sio Capital Management reported no remaining Bionano Genomics position as of Q2 2021 after selling out during the quarter.
  • Sio Capital Management sold 40 Bionano Genomics shares in Q2 2021, an estimated $196K.
  • Sio Capital Management first reported a position in Bionano Genomics in Q3 2018 and held it in 9 quarters.
  • Sio Capital Management's Bionano Genomics position peaked at $7.35M in Q3 2018.
  • 152 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2021.

Based on Sio Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.